PharMerica Joins DC-Based Senior Care Pharmacy Coalition (SCPC) Citing Need for Effective, Focused Advocacy on Long Term Care (LTC) Pharmacy Issues

Washington, DC – The Senior Care Pharmacy Coalition (SCPC), the only national organization dedicated exclusively to the highly-specific legislative and regulatory interests of America’s growing and dynamic long term care (LTC) pharmacy sector and the patients they serve, today welcomed as a new member PharMerica Corporation (NYSE: PMC), a major national provider of LTC pharmacy read more…

SCPC, ASCP, AHCA/NCAL Letter to FDA: Facts Caution Against Imposition of Inappropriate New Regulatory Burdens on Nation’s Long Term Care (LTC) Pharmacies, Patients

Washington, DC — The Senior Care Pharmacy Coalition (SCPC), the American Society of Consultant Pharmacists (ASCP), the American Health Care Association and the National Center for Assisted Living (AHCA/NCAL) have sent a new letter to the Food and Drug Administration (FDA) commenting on the Agency’s draft Repackaging Guidance, and educating the Agency about long term care (LTC) pharmacy operations….Read More

Re: Objection to Texas Medicaid State Plan Amendment Transmittal Number 15-005

The Texas Health and Human Services Commission (HHSC) submitted a proposed State Plan Amendment (SPA)1 (Transmittal Number 15-005) in May 2016 as a response to the final CMS Covered Outpatient Drug Rule (CMS-2345-FC)2 that went into effect this April…Read More

SCPC Hails Senate Passage of CARA, Thanks Lawmakers in Both Chambers for Recognizing Key Role Played by LTC Pharmacies in Seniors’ Medication Management

Washington, DC – Characterizing Senate passage of the Comprehensive Addiction and Recovery Act (CARA) as “a major victory for the nation’s long term care (LTC) pharmacy sector and the patients under their care,” the Senior Care Pharmacy Coalition (SCPC) today thanked key U.S. Senate and House leaders who helped shepherd-through a lengthy, complex legislative process, a vital provision that recognizes the key role played by LTC pharmacies in seniors’ medication management…Read More

FDA Compounding Listening Session Beneficial to Reiterate the Unique Role, Value of Long Term Care (LTC) Pharmacies

Washington, DC – In thanking the Food and Drug Administration (FDA) for holding a recent listening session regarding provisions of the Drug Quality and Security Act (DQSA), Senior Care Pharmacy Coalition (SCPC) President and CEO, Alan G. Rosenbloom, said the gathering served as a productive forum to reiterate the need for FDA to ensure its implementation does not inadvertently create unanticipated burdens on dispensing practices in specialized settings like LTC facilities and pharmacies…Read More

Growing Scrutiny of Sketchy, Illusory Pharmacy Benefit Manager (PBM) Value Proposition Forces PCMA to Initiate Defensive DC PR Campaign

Placed on the defensive by a growing level of congressional scrutiny and unfavorable publicity surrounding lawsuits against the shadowy pharmacy benefit manager (PBM) industry, the Senior Care Pharmacy Coalition (SCPC) noted the Pharmaceutical Care Management Association (PCMA) is being forced to mount a defensive public relations effort to counter the growing perception that PBMs are anti-consumer, anti-taxpayer and anti-free market….Read More

SCPC Lauds CARA Final Senate Passage, Praises Key Toomey Provision Protecting Long-Term Care Patients’ Access to Essential Medications

Washington, DC — In praising today’s Senate passage of the Comprehensive Addiction and Recovery Act (CARA), the Senior Care Pharmacy Coalition (SCPC) thanked Senators Rob Portman (R-OH), Kelly Ayotte (R-NH), Mark Kirk (R-IL), Sheldon Whitehouse (D-RI), Amy Klobuchar (D-MN) and Christopher Coons (D-DE) and their colleagues in the U.S. Senate for helping place the nation’s opioid abuse epidemic front and center in the public spotlight…Read More

Independent LTC Pharmacy Advocacy Group Urges Stronger Effort on PDP Transparency in Response to CMS Draft 2017 Medicare Part D Call Letter

In response to the Centers for Medicare and Medicaid Service’s (CMS) draft 2017 Part D Call letter, the Senior Care Pharmacy Coalition (SCPC) urged still more rigorous efforts to ensure greater prescription drug plan (PDP) transparency in regard to Maximum Allowable Cost (MAC) pricing – despite a recent CMS initiative to do so…Read More

SCPC Comments on the CMS Draft 2017 Medicare Part D Call Letter

The Senior Care Pharmacy Coalition (“SCPC”) appreciates the opportunity to provide the following comments to the Center for Medicare and Medicaid Service’s (“CMS”) draft 2017 Part D Call Letter, dated February 19, 2016 (the “Call Letter”)….Read More

SCPC Praises Bipartisan Collins-Loebsack Letter Advancing Investigation of PBMs’ Anti-Competitive, Non-Transparent Pricing Practices

The Senior Care Pharmacy Coalition (SCPC) today praised U.S. Reps. Doug Collins (R-GA) and Dave Loebsack (D-IA) for issuing a letter with fourteen colleagues urging the Chairmen of the U.S. House Energy and Commerce, Ways and Means and Armed Services Committees to examine the importance of passing the MAC Transparency Act (H.R. 244) in advancing payment transparency in regard to how Pharmacy Benefit Managers (PBMs) reimburse a variety of pharmacy groups, including LTC pharmacies, for generic drugs administered to patients…Read More

Twitter   LinkedIn